Latest Strategy Changes News

Sarama Resources has secured A$2.7 million to advance exploration at its Cosmo and Mt Venn gold projects in Western Australia, while arbitration over its lost Burkina Faso permit progresses.

Sarama Resources Ltd reported a $1.22 million net loss for the first half of 2025, while completing a $2.7 million equity placement and acquiring a majority stake in the Mt Venn Gold Project in Western Australia.

Amcor has completed its transformative acquisition of Berry Global, reporting a 43% jump in quarterly net sales and projecting strong earnings growth for fiscal 2026. The company’s strategic portfolio review and synergy realisation efforts underpin an optimistic outlook.

Baby Bunting delivered a standout FY25 with pro forma NPAT soaring 228% to $12.1 million, driven by record sales and a successful store refurbishment program. The retailer’s growth strategy is gaining momentum as it plans an aggressive rollout of its ‘Store of the Future’ concept.

Laramide Resources has made significant progress in advancing its uranium projects across the US, Australia, and Kazakhstan, highlighted by key permitting milestones under the US FAST-41 framework and a successful $12 million private placement to fund development.

Laramide Resources Ltd. reported a reduced net loss of CAD 1.05 million for H1 2025, converting USD 3.5 million of debt into equity and securing a $12 million private placement to bolster its uranium exploration projects.

Baby Bunting Group Limited reported a remarkable 462% increase in statutory net profit after tax for FY2025, driven by strong sales growth and strategic store refurbishments. The company also advanced its sustainability initiatives and expanded its digital and retail media businesses.

Meridian Energy's July report reveals a notable decline in hydro storage levels alongside a surge in retail electricity sales, highlighting a complex energy landscape in New Zealand.

Cochlear Limited reported a solid FY25 with 4% revenue growth and a 1% rise in underlying profit, underpinned by new product launches and expanding evidence linking implants to reduced dementia risk. The company’s FY26 outlook signals further gains as it advances market leadership and innovation.

Cochlear Limited reported a 4% revenue rise in FY25, driven by strong implant sales and launched the world’s first smart cochlear implant system. The company forecasts up to 17% profit growth in FY26, underpinned by innovation and expanding markets.

Cochlear Limited has reported steady financial growth with a 4% rise in sales revenue and a 9% increase in underlying net profit for the fiscal year ending June 2025, maintaining its dividend payout.

HealthCo Healthcare and Wellness REIT reported a substantial $89.3 million loss for FY25, driven by tenant payment issues and portfolio downsizing, leading to suspended distributions and a debt facility extension.